Aquestive Therapeutics (AQST) Enterprise Value (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Enterprise Value of -$110.7 million for Q1 2026, down 61.29% year-over-year from -$286.0 million in Q1 2025, and up 8.61% quarter-over-quarter from -$121.2 million in Q4 2025.
Aquestive Therapeutics (AQST) Enterprise Value (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Enterprise Value history runs 10 years deep, the most recent figure standing at -$110.7 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 61.29% year-over-year to -$110.7 million; the TTM figure through Mar 2026 stood at -$110.7 million (down 61.29% YoY), while the FY2025 annual figure was -$121.2 million, down 69.36% from the prior year.
- Enterprise Value for Q1 2026 stood at -$110.7 million, up from -$121.2 million in the prior quarter.
- The five-year high for Enterprise Value was -$14.7 million in Q1 2022, with the low at -$129.1 million in Q3 2025.
- The 5-year median for Enterprise Value is -$60.5 million (2025), against an average of -$58.9 million.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value soared 48.31% in 2022, then plunged 300.56% in 2024.
- Aquestive Therapeutics' Enterprise Value stood at -$27.3 million in 2022, then grew by 12.47% to -$23.9 million in 2023, then slumped by 199.71% to -$71.5 million in 2024, then plunged by 69.36% to -$121.2 million in 2025, then rose by 8.61% to -$110.7 million in 2026.
- Business Quant data shows AQST's Enterprise Value at -$110.7 million in Q1 2026, -$121.2 million in Q4 2025, and -$129.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | -164.00 Mn |
| 10 | Aquestive Therapeutics | 553.72 Mn | 553.72 Mn | 9.80 Mn | -98.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -98.49 Mn |
| Mar 31, 2026 | -110.73 Mn |
| Dec 31, 2025 | -121.17 Mn |
| Sep 30, 2025 | -129.06 Mn |
| Jun 30, 2025 | -60.54 Mn |
| Mar 31, 2025 | -68.66 Mn |
| Dec 31, 2024 | -71.55 Mn |
| Sep 30, 2024 | -77.89 Mn |
| Jun 30, 2024 | -89.87 Mn |
| Mar 31, 2024 | -95.20 Mn |
| Dec 31, 2023 | -23.87 Mn |
| Sep 30, 2023 | -24.92 Mn |
| Jun 30, 2023 | -22.44 Mn |
| Mar 31, 2023 | -26.88 Mn |
| Dec 31, 2022 | -27.27 Mn |
| Sep 30, 2022 | -18.65 Mn |
| Jun 30, 2022 | -17.70 Mn |
| Mar 31, 2022 | -14.74 Mn |
| Dec 31, 2021 | -28.02 Mn |
| Sep 30, 2021 | -31.16 Mn |